Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 28, 2012 Nov 27, 2012
Oculus Innovative Sciences to Create Subsidiary for Company's Anti-Infective Drug Assets Nov 26, 2012
Oculus Innovative Sciences Completes Patient Enrollment in Study of Microcyn(R) Hydrogel in Management of Scars Nov 14, 2012
Oculus Innovative Sciences Announces Publication of Results From Study of Microcyn(R) Technology-Based Antipruritic Hydrogel in Treatment of Atopic Dermatitis Sep 27, 2012
Oculus Innovative Sciences Updates Guidance: Faster Path to Positive EBITDAS as Result of Recent Partnership Sep 20, 2012
Photo Release -- Napa Valley Nutritionals Launches Glucorein(TM) Medical Food for Dietary Management of Polycystic Ovary Syndrome (PCOS) Sep 18, 2012
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology Sep 11, 2012
Oculus Innovative Sciences to Present at the Rodman & Renshaw 14th Annual Healthcare Conference on September 10th in New York City Sep 5, 2012
Oculus Innovative Sciences Enrolls First Patient in Study of Microcyn(R) Hydrogel in Management of Scars Aug 16, 2012
